US Congress Senate Bill 2994 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on May 26 2016 - 25% progression, died in committee
Action: 2016-05-26 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

DXM Abuse Prevention Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Civil monetary penalties that escalate upon repeated violation are imposed. To possess or receive unfinished DXM, a person must be registered with the Department of Health and Human Services as a producer of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Unfinished DXM may be distributed only to these authorized persons. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations.

DXM Abuse Prevention Act of 2016

Sen. Robert Casey [D-PA]

Sen. Lisa Murkowski [R-AK]

Date	Chamber	Action
2016-05-26	Senate	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

HB3250 (Related) 2016-07-08 - Placed on the Union Calendar, Calendar No. 520.

Type	Source
Summary	https://www.congress.gov/bill/114th-congress/senate-bill/2994/all-info
Text	https://www.congress.gov/114/bills/s2994/BILLS-114s2994is.pdf